Clinical Trial Update: Clinical Study for Dimethyl Fumarate in Preserving Islet β-Cell Function in Type 1 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating dimethyl fumarate for preserving islet beta-cell function in Type 1 diabetes mellitus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Dimethyl fumarate (Dimethyl fumarate)

Snippet

Sponsor: Nanjing Medical University | Conditions: Type 1 Diabetes | Phase 3 | Status: RECRUITING